Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.555 USD | +2.20% | +7.87% | +8.80% |
Apr. 04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
Feb. 29 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.80% | 35.25M | |
+25.84% | 661B | |
+26.74% | 566B | |
-6.67% | 352B | |
+20.41% | 332B | |
+2.72% | 283B | |
+13.51% | 231B | |
+4.69% | 200B | |
-9.41% | 195B | |
-5.22% | 145B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q4 Revenue $76,000